Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017 (2017), Article ID 3506871, 7 pages
https://doi.org/10.1155/2017/3506871
Research Article

The Determinants of Leptin Levels in Diabetic and Nondiabetic Saudi Males

Department of Physiology, College of Medicine, University of Dammam, Dammam, Saudi Arabia

Correspondence should be addressed to Mona Hmoud Al Sheikh

Received 19 September 2016; Revised 28 November 2016; Accepted 20 December 2016; Published 1 March 2017

Academic Editor: Małgorzata Kotula-Balak

Copyright © 2017 Mona Hmoud Al Sheikh. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. Lavie, R. V. Milani, and H. O. Ventura, “Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss,” Journal of the American College of Cardiology, vol. 53, no. 21, pp. 1925–1932, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Blüher and C. Mantzoros, “Leptin in humans: lessons from translational research,” The American Journal of Clinical Nutrition, vol. 89, no. 3, pp. 991S–997S, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Fortuno, A. Rodriguez, J. Gomez-Ambrosi, G. Fruhbeck, and J. Diez, “Adipose tissue as an endocrine organ: role of leptin and adiponectin in pathogenesis of cardiovascular diseases,” Journal of Physiology and Biochemistry, vol. 59, no. 1, pp. 51–60, 2003. View at Publisher · View at Google Scholar
  4. D. Gruszfeld, Z. Kułaga, A. Wierzbicka et al., “Childhood obesity risk and prevention: shining a lens on the first 1000 days,” Childhood Obesity, vol. 12, no. 3, pp. 179–187, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Gligor, M. Puschita, D. Zdremtan, I. Crisnic, and C. Ionescu-Tirgoviste, “Relationship between adiponectin and some metabolic parameters in obese and non-diabetic patients,” Farmacia, vol. 60, no. 2, pp. 293–306, 2002. View at Google Scholar
  6. A. Stofkova, “Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity,” Endocrine Regulations, vol. 44, no. 1, pp. 25–36, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Takebayashi, M. Suetsugu, S. Wakabayashi, Y. Aso, and T. Inukai, “Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus,” Metabolism, vol. 56, no. 4, pp. 451–458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Steppan, S. Bailey, and S. Bhat, “The hormone resistin links obesity to diabetes,” Nature, vol. 409, no. 6818, pp. 307–312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Trayhurn, B. Wang, and S. Wood, “Hypoxia in adipose tissue: a basis for the dysregulation of tissue functions in obesity?” The British Journal of Nutrition, vol. 100, no. 2, pp. 227–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Fantuzzi, “Adipose tissue, adipokines, and inflammation,” The Journal of Allergy and Clinical Immunology, vol. 115, no. 5, pp. 911–920, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Kershaw and J. Flier, “Adipose tissue as an endocrine organ,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 6, pp. 2548–2556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Gualillo, “Further evidence for leptin involvement in cartilage homeostasis,” Osteoarthritis and Cartilage, vol. 15, no. 8, pp. 857–860, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Momose, A. Inui, A. Asakawa et al., “Intracerebroventricularly administered corticotropin-releasing factor inhibits food intake and produces anxiety-like behaviour at very low doses in mice,” Diabetes, Obesity & Metabolism, vol. 1, no. 5, pp. 281–284, 1999. View at Publisher · View at Google Scholar
  14. P. Tatti, L. Masselli, A. Buonanno, P. Di Mauro, and F. Strollo, “Leptin levels in diabetic and nondiabetic subjects,” Endocrine, vol. 15, no. 3, pp. 305–308, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Considine, M. Sinha, M. Heiman et al., “Serum immunoreactive-leptin concentrations in normal-weight and obese humans,” The New England Journal of Medicine, vol. 334, no. 5, pp. 292–295, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Mohiti and J. Doudi, “Relation between leptin and insulin in patients with type 2 diabetes mellitus,” Turkish Journal of Endocrinology and Metabolism, vol. 9, no. 2, pp. 55–58, 2003. View at Google Scholar
  17. J. Tuominen, P. Ebeling, U. Stenman, M. Heiman, T. Stephens, and V. Koivisto, “Leptin synthesis is resistant to the acute effects of insulin in insulin-dependent diabetes mellitus patients,” The Journal of Clinical Endocrinology & Metabolism, vol. 82, no. 2, pp. 381–382, 1997. View at Publisher · View at Google Scholar
  18. P. Scarpace, M. Matheny, and Y. Zhang, “Wheel running eliminates high-fat preference and enhances leptin signaling in the ventral tegmental area,” Physiology & Behavior, vol. 100, no. 2, pp. 173–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Scherer, S. Williams, M. Fogliano, G. Baldini, and H. Lodish, “A novel serum protein similar to C1q, produced exclusively in adipocytes,” The Journal of Biological Chemistry, vol. 270, no. 45, pp. 26746–26749, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Jurimae, P. Purge, and T. Jurimae, “Adiponectin and stress hormone responses to maximal sculling after volume-extended training season in elite rowers,” Metabolism, vol. 55, no. 1, pp. 13–19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Carr, R. Patel, V. Rao et al., “Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice,” American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, vol. 302, no. 8, pp. R996–R1003, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Samal, Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece, “Cloning and characterization of the cDNA encoding a novel human pre-B-cellcolony-enhancing factor,” Molecular and Cellular Biology, vol. 14, no. 2, pp. 1431–1437, 1994. View at Publisher · View at Google Scholar
  23. A. Fukuhara, M. Matsuda, M. Nishizawa et al., “Visfatin: a protein secreted by visceral fat that mimics the effects of insulin,” Science, vol. 307, no. 5708, pp. 426–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. T. H. Meek, M. E. Matsen, V. Damian, A. Cubelo, S. C. Chua, and G. J. Morton, “Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes,” Endocrinology, vol. 155, no. 11, pp. 4157–4167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Marín-Juez, S. Jong-Raadsen, S. Yang, and H. Spaink, “Hyperinsulinemia induces insulin resistance and immune suppression via Ptpn6/Shp1 in zebrafish,” Journal of Endocrinology, vol. 222, no. 2, pp. 229–241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Kulkarni, Z. Wang, R. Wang et al., “Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice,” The Journal of Clinical Investigation, vol. 100, no. 11, pp. 2729–2736, 1997. View at Publisher · View at Google Scholar
  27. T. Nohira, K. Nagao, K. Kameyama et al., “Identification of an alternative splicing transcript for the resistin gene and distribution of its mRNA in human tissue,” European Journal of Endocrinology, vol. 151, no. 1, pp. 151–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Rongvaux, R. Shea, M. Mulks, D. Gigot, and J. Urbain, “Pre-B-cell colony enhancing factor, whose expression is up-regulatedin activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis,” European Journal of Immunology, vol. 32, no. 11, pp. 3225–3234, 2002. View at Publisher · View at Google Scholar
  29. M. Cnop, M. Landchild, and J. Vidal, “The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments,” Diabetes, vol. 51, no. 4, pp. 1005–1015, 2002. View at Publisher · View at Google Scholar
  30. M. Abu-Sayeed, A. K. Azad Khan, H. Mahtab et al., “Leptin is reduced in lean subjects with type 2 diabetes in Bangladesh,” Diabetic Care, American Diabetic Association, vol. 26, no. 2, 547 pages, 2003. View at Google Scholar
  31. M. Abdelgadir, M. Elbagir, M. Eltom, C. Berne, and B. Ahren, “Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan,” Metabolism, vol. 51, no. 3, pp. 304–306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Liu, M. Matsuda, S. Mahankali et al., “Altered hypothalamic function in response to glucose ingestion in obese humans,” Diabetes, vol. 48, no. 9, pp. 1801–1806, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Haffner, M. Stern, H. Miettinen, M. Wei, and R. Gingerich, “Leptin concentrations in diabetic and nondiabetic Mexican-Americans,” Diabetes, vol. 45, no. 6, pp. 822–824, 1996. View at Publisher · View at Google Scholar
  34. G. Mohammadzadeh and N. Zarghami, “Serum leptin level is reduced in non-obese subjects with type 2 diabetes,” International Journal of Endocrinology and Metabolism, vol. 11, no. 1, pp. 3–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Maahs, R. Hamman, R. D'Agostino et al., “The association between adiponectin/leptin ratio and diabetes type: the SEARCH for Diabetes in Youth Study,” The Journal of Pediatrics, vol. 155, no. 1, pp. 133–135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Schmidt, B. Duncan, A. Vigo et al., “Leptin and incident type 2 diabetes: risk or protection?” Diabetologia, vol. 49, no. 9, pp. 2086–2096, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. Q. Sun, R. Van Dam, J. Meigs, O. Franco, C. Mantzoros, and F. Hu, “Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study,” Diabetes, vol. 59, no. 3, pp. 611–618, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Welsh, H. Murray, B. Buckley et al., “Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population,” Diabetes Care, vol. 32, no. 2, pp. 308–310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. M. McNeely, E. Boyko, D. Weigle et al., “Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans,” Diabetes Care, vol. 22, no. 1, pp. 65–70, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Soderberg, P. Zimmet, J. Tuomilehto et al., “Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study,” International Journal of Obesity, vol. 31, no. 7, pp. 1126–1133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Bandaru and A. Shanker, “Association between plasma leptin levels and diabetes mellitus,” Metabolic Syndrome and Related Disorders, vol. 9, no. 1, pp. 19–23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Ahren, T. Gudbjartsson, A. Al-Amin et al., “Islet perturbations in rats fed a high-fat diet,” Pancreas, vol. 18, no. 1, pp. 75–83, 1999. View at Publisher · View at Google Scholar
  43. M. Matsubara, S. Maruoka, and S. Katayose, “Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women,” European Journal of Endocrinology, vol. 147, no. 2, pp. 173–180, 2002. View at Publisher · View at Google Scholar
  44. A. Esteghamati, S. Noshad, O. Khalilzadeh, A. Morteza, and A. Nazeri, “Contribution of serum leptin to metabolic syndrome in obese and non-obese subjects,” Archives of Medical Research, vol. 42, no. 3, pp. 244–251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Staiger, S. Kaltenbach, K. Staiger et al., “Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism,” Diabetes, vol. 53, no. 9, pp. 2195–2201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Smith, F. J. Elgar, C. Roberts, and L. Moore, “Sedentary behaviour, physical activity and weight problems in adolescents in Wales,” Public Health, vol. 119, no. 6, pp. 518–524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Weyer, M. Tschöp, P. Tataranni, V. Devanarayan, E. Ravussin, and M. Heiman, “Circulating ghrelin levels are decreased in human obesity,” Diabetes, vol. 50, no. 4, pp. 707–709, 2001. View at Publisher · View at Google Scholar
  48. Y. Arita, S. Kihara, N. Ouchi et al., “Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity,” Biochemical and Biophysical Research Communications, vol. 257, no. 1, pp. 79–83, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Ebihara, Y. Ogawa, H. Masuzaki et al., “Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes,” Diabetes, vol. 50, no. 6, pp. 1440–1448, 2001. View at Publisher · View at Google Scholar
  50. H. Hiroso, I. Saito, H. Kawabe, and T. Saruta, “Insulin resistance and hypertension: seven-year follow-up study in middle-aged Japanese men (the KEIO Study),” Hypertension Research, vol. 26, no. 10, pp. 795–800, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. O. Njajou, A. Kanaya, P. Holvoet et al., “Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health Aging and Body Composition study,” Diabetes/Metabolism Research and Reviews, vol. 25, no. 8, pp. 733–739, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Adeghate, “Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions,” Current Medicinal Chemistry, vol. 15, no. 18, pp. 1851–1862, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Banks, B. Alan, M. Coon et al., “Triglycerides induce leptin resistance at the blood-brain barrier,” Diabetes, vol. 53, no. 5, pp. 1253–1260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Lichnovsak, S. Gwozdziewiczova, R. Chlup, and J. Hrebicek, “Serum leptin in the development of insulin resistance and other disorders in the metabolic syndrome,” Biomedical Papers, vol. 149, no. 1, pp. 119–126, 2005. View at Publisher · View at Google Scholar
  55. T. Patrizio, P. Desiderio, and P. Luisa, “The undisclosed role of anoxia/hypoxia and disturbed sleep on glucose metabolism,” Journal of Diabetes Mellitus, vol. 2, no. 2, pp. 186–190, 2012. View at Publisher · View at Google Scholar
  56. M. Pelleymounter, M. Cullen, B. Baker et al., “Effects of the obese gene product on body weight regulation in ob/ob mice,” Science, vol. 269, no. 5223, pp. 540–543, 1995. View at Publisher · View at Google Scholar
  57. G. Marchesini, E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, and R. Manini, “Non-alcoholic fatty liver, steatohepatitis, and the metabolic syndrome,” Hepatology, vol. 37, no. 4, pp. 917–923, 2003. View at Publisher · View at Google Scholar · View at Scopus